LISTEN: Investors are betting $3.3 billion that your gut is the next frontier for the hottest part of healthcare
Samantha Lee/Business Insider
- Several high-profile startups that promised to draw insights from the bacteria living in and on us, known as the microbiome, have failed in recent months.
- One of them, a company called uBiome, which was valued at $600 million, said it would shut down on October 1 after months of challenges and setbacks.
- But investors still see the microbiome as a lucrative opportunity for the burgeoning digital-health industry, which has raked in $37.6 billion from investors since 2011.
- Here's how the microbiome companies they're betting on plan to succeed.
- Listen to this story below, or read it in full right here.
NOW WATCH: Why plane tires don't explode during landing
- Here is why a ban on cryptocurrencies may not be even possible
- Chiacoin claims to be an eco-friendly cryptocurrency — here's how it works
- SII's Adar Poonawalla says it will take 2-3 years for the entire world population to get fully vaccinated
- India surpasses Brazil with more than 200 journalists succumbing to COVID-19 pandemic
- If you have taken Covishield shots, watch out for these blood clot symptoms listed out by India’s Health Ministry